Company Description
XOMA doesn't want to toil in anonymity. Instead, the company pairs with larger drug firms to develop and market its products, primarily monoclonal...
Key XOMA Financials
| Company Type | Public - NASDAQ (GM): XOMA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $84.3 |
| 2005 Employees | 219 |
More XOMA Financials (11 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about XOMA's competition across multiple industries
Top XOMA Competitors
Sponsored Links
The Business Directory
XOMA Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| VP Finance and CFO; Acting Head, Proprietary Products | J. David Boyle II | Network | E-mail |
| VP Human Resources and Information Technology | Charles C. (Chris) Wells | Network | E-mail |
| VP Operations; Head, Biodefense | Robert S. (Rob) Tenerowicz | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current XOMA News
- XOMA Ltd(GAAP) (XOMA.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 05:00:00 EDT)
-
XOMA Ltd (NASD:XOMA) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 01:02:00 EDT) - Briefing.com: Hourly In Play (R) - 00:00 ET [Briefing.com] (17 May 2008 00:00:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.